Children with disabilities <a href=" http://www.fitxpress.com/extra-super-zhewitra/ ">zhewitra</a> Prescriptions for HRT started to decline after 2002 after the landmark Women's Health Initiative (WHI) showed combined estrogen and progestin therapy increased women's risk of breast cancer, heart disease and stroke compared with taking a placebo. Now a followup study, published in Tuesday's issue of JAMA, reaffirms those findings and clearly makes a distinction about short-term use of hormone therapy in early menopause.